Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs COMP✓SelectedUSD · COMPGSK vs COMP performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs COMP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+78.6%
COMP return
-52.0%
Excess return
+130.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCOMPExcessAlpha
1D+0.5%+1.7%-1.2%+0.5%
7D+1.1%0.0%+1.1%+1.1%
30D+6.3%+16.6%-10.2%+5.9%
3M+1.8%-23.5%+25.3%+2.3%
6M+1.7%+25.7%-24.1%+1.0%
YTD+6.5%-3.4%+10.0%+6.1%
1Y+9.5%+7.6%+1.9%+8.7%
3Y+65.3%+423.6%-358.3%+57.5%
5Y+43.7%-10.6%+54.3%+41.8%
All+78.6%-52.0%+130.6%+80.5%

Cumulative growth

Daily Returns

Daily percentage return beside COMP.

Daily Out/Under-Performance

Portfolio return minus COMP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × COMP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded COMP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling